Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-05

FDA Approved: OMEPRAZOLE — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved BluePoint Laboratories' original ANDA for a generic omeprazole product. Omeprazole is a proton pump inhibitor indicated for gastroesophageal reflux…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

ORIG AP for OMEPRAZOLE (OMEPRAZOLE)